Skip to main content
SpringerLink
Log in

Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Alfrey EJ, Friedman AL, Grossman RA, Perloff LJ, Naji A, Barker CF, Montone KT (1992) A recent decrease in the time to development of monomorphous and polymorphous post-transplant lymphoproliferative disorder. Transplantation 54:250

    PubMed  Google Scholar 

  2. Armitage JM, Kormos RL, Stuart S, Fricker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS (1991) Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporin-based immunosuppression. J Heart Lung Transplant 10:877

    PubMed  Google Scholar 

  3. Baer R, Bankier AT, Biggin MD, Deninger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Sequin G, Tuffnell PS, Barrell BG (1984) DNA sequence and expression of the B958-Epstein-Barr virus genome. Nature 310:207

    PubMed  Google Scholar 

  4. Beveridge T, Krupp P, McKibbin C (1984) Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy. Lancet 1:788

    Google Scholar 

  5. Birkeland SA (1983) Cancer in cadaver kidney transplant patients. Surgery 93:504

    PubMed  Google Scholar 

  6. Bogedain C, Wolf H, Modrow S, Stuber G, Jilg W (1995) Specific cytotoxic T lymphocytes recognise the immediate early transactivator Zta of Epstein-Barr virus. J Virol 69:4872

    PubMed  Google Scholar 

  7. Bourgault I, Gomez A, Gomard E, Levy JP (1991) Limiting dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clin Exp Immunol 84:501

    PubMed  Google Scholar 

  8. Burman K, Crawford DH (1991) Effect of FK506 on Epstein-Barr virus specific cytotoxic T cells. Lancet 337:297

    PubMed  Google Scholar 

  9. Callan MFC, Steven N, Krausa P, Wilson JDK, Moss PAH, Gillespie, Bell JI, Rickinson AB, McMichael AJ (1996) Large clonal expansion of CD8+T cells in acute mononucleosis. Nat Med 2:906

    PubMed  Google Scholar 

  10. Cen H, Breinig MC, Atchison RW, Ho M, McKnight JLC (1991) Epstein-Barr virus transmission via the donor organ in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3 and IR4. J Virol 65:976

    PubMed  Google Scholar 

  11. Cox KL, Lawrence-Miyasaki, Garcia-Kennedy, Lennette ET, Martinez OM, Krams SM, Brequist WE, Esquivel CO (1995) An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 59:524

    PubMed  Google Scholar 

  12. Crawford DH, Epstein MA, Bornkamn GW, Achong BG, Finerty S, Thompson JL (1980) Epstein-Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in a patient with renal allograft. Lancet 1:1355

    PubMed  Google Scholar 

  13. Epstein MA, Crawford DH (1998) Gamma-herpes-viruses: Epstein-Barr virus. In: Collier L, Balows A, Sussman M (eds) Topley and Wilson's microbiology and microbial infections, 9th edn, vol 1. Arnold, London, pp 351–366

    Google Scholar 

  14. Gratama JW, Oosterveer MAP, Zwaan FE, Lepoutre J, Klein G, Ernberg I (1988) Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci USA 85:8693

    PubMed  Google Scholar 

  15. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH, Simmons RL, Najarian JS (1982) Acyclovir therapy and transition from polyclonal to monoclonal B cell proliferation. N Engl J Med 306:913

    PubMed  Google Scholar 

  16. Haque T, Thomas JA, Falk K, Parratt R, Hunt B, Yacoub M, Crawford DH (1996) Transmission of donor Epstein-Barr virus in transplanted organ causes lymphoproliferative diseases in recipient. J Gen Virol 77:1169

    PubMed  Google Scholar 

  17. Haque T, Thomas JA, Parratt R, Hunt B, Yacoub M, Crawford DH (1997) A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events. Transplantation 64:1028

    PubMed  Google Scholar 

  18. Haque T, Amlot P, Helling N, Thomas JA, Sweny P, Rolles K, Burroughs A, Prentice HG, Crawford DH (1998) Restoration of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol 160:6204

    PubMed  Google Scholar 

  19. Henle G, Henle W (1979) The virus as the etiologic agent of infectious mononucleosis. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 297–320

    Google Scholar 

  20. Henle G, Henle W, Diehl W (1968) Relation of Burkitt's tumour-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 59:94

    PubMed  Google Scholar 

  21. Ho M, Miller G, Wayne A, Breinig M, Dummer J, Andiman W, Starzl T, Eastman R, Griffith BP, Hardesty R, Bahnson H, Hakala T, Rosenthal J (1985) Epstein-Barr virus infection and DNA hybridisation studies in post-transplant lymphomas and lymphoproliferative lesions: the role of primary infection. J Infect Dis 152:876

    PubMed  Google Scholar 

  22. Ho M, Jaffe R, Miller G, Breinig MK, Dummer IS, Makowka L, Atchison RW, Karrer F, Nalesnik MA, Starzl TE (1988) The frequency of Epstein-Barr virus infection and associated lymphoproliferative disease after transplantation and its manifestations in children. Transplantation 45:719

    PubMed  Google Scholar 

  23. Kieff E (1996) Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology, 3rd edn. Lippincott-Raven, Philadelphia, pp 2343–2396

    Google Scholar 

  24. Kino T, Hatanaka H, Miyata S (1987) FK-506, a novel immunosuppressant isolated from Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 40:1256

    Google Scholar 

  25. Kroes ACM, Brouwer ML, Batenburg M van, Balk AHMM (1991) Primary Epstein-Barr virus (EBV) infection in an immunosuppressed patient: symptoms, serology and T cell response. J Infect Dis 163:1385

    PubMed  Google Scholar 

  26. Levitskaya J, Coram M, Levitsky V, hutch S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen 1. Nature 375:685

    PubMed  Google Scholar 

  27. Miyashita EM, Yang B, Lam KMC, Crawford DH, Thorley-Lawson DA (1995) A novel form of Epstein-Barr virus latency in normal B cells. Cell 80:593

    PubMed  Google Scholar 

  28. Moss DJ, Wallace LE, Rickinson AB, Epstein MA (1981) Cytotoxic T cell recognition of Epstein-Barr virus infected B cells. I: specificity and HLA-restriction of effector cells reactivated in vitro. Eur J Immunol 11:686

    PubMed  Google Scholar 

  29. Murray RJ, Kurilla SR, Moss DJ, Griffith HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E (1990) Human cytotoxic T cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc Natl Acad Sci USA 87:2906

    PubMed  Google Scholar 

  30. Nalesnik MA (1990) Involvement of the gastrointestinal tract by Epstein-Barr virus-associated posttransplant lymphoproliferative disorders. Am J Surg Pathol 14:92

    PubMed  Google Scholar 

  31. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol 133:173

    PubMed  Google Scholar 

  32. Opelz G, Henderson R (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342:1514

    PubMed  Google Scholar 

  33. Papadopoulos EB, Ladanyi M, Emanuel D (1994) Infusions of donor leukocytes to treat Epstein-Barr-virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330:1185

    PubMed  Google Scholar 

  34. Penn I, Porat G (1995) Central nervous system lymphomas in organ allograft recipients. Transplantation 59:240

    PubMed  Google Scholar 

  35. Perera SM, Johannessen I, Thomas JA, Brooks LA, N'Jie Jobe J, Crawford DH (1997) Growth of Epstein-Barr virus-associated B lymphoproliferative disease tissue in a severe combined immunodeficient mouse. Blood 88:1123

    Google Scholar 

  36. Perera SM, Thomas JA, Burke M, Crawford DH (1998) Analysis of the T cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease. J Pathol 184:177

    PubMed  Google Scholar 

  37. Pope JH, Horne MK, Scott W (1968) Transformation of human foetal leucocytes in vitro by infiltrates of a human leukaemia cell line containing herpes-like virus. Int J Cancer 3:857

    PubMed  Google Scholar 

  38. Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J (1989) The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heartlung transplant recipients. Am J Clin Pathol 92:177

    PubMed  Google Scholar 

  39. Renard TH, Andrews WS, Foster ME (1991) Relationship between OKT3 administration, EBV seroconversion and the lymphopriliferative syndrome in pediatric liver transplant recipients. Transplant Proc 23:1473

    PubMed  Google Scholar 

  40. Rocchi G, Felici AD, Ragona G, Heinz A (1977) Quantitative evaluation of Epstein-Barr virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N Engl J Med 296:132

    PubMed  Google Scholar 

  41. Rooney CM, Smith CA, Ng CYC (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345:9

    PubMed  Google Scholar 

  42. Savoie A, Perpete C, Carpentier L, Joncas J, Alfieri C (1994) Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of paediatric transplant patients and risk of lymphoproliferative disease. Blood 9:2715

    Google Scholar 

  43. Sixbey JW, Vesterinen EH, Nedrud JG, Raab-Traub N, Walton LA, Pagano IS (1983) Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 306:480

    PubMed  Google Scholar 

  44. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Epstein-Barr-virus replication in oropharyngeal epithelial cells. N Engl J Med 310:1225

    PubMed  Google Scholar 

  45. Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B, Ramsay NKC, McGlave P, Filipovich AH (1988) Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234

    PubMed  Google Scholar 

  46. Starzl TF, Proter DA, Iwatusuki S (1984) Reversibility of lymphomas or lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583

    PubMed  Google Scholar 

  47. Stevens NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB (1997) Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med 185:1605

    PubMed  Google Scholar 

  48. Tierney RJ, Steven N, Young LS, Rickinson AB (1994) Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374

    PubMed  Google Scholar 

  49. Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, Crawford DH (1990) Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49:292

    Google Scholar 

  50. Thomas JA, Crawford DH, Burke M (1995) Clinicopathological implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients. J Clin Pathol 48:287

    PubMed  Google Scholar 

  51. Tsoukas CD, Carson DA, Fong S, Vaughan JH (1982) Molecular interactions in human T cell-mediated cytotoxicity to EBV 11. Monoclonal antibody OKT3 inhibits a post-killer recognition/adhesion step. J Immunol 129:1421

    PubMed  Google Scholar 

  52. Van Gelder T, Kroes LCM, Mulder A, Gratama JW, Weimer W (1994) A living-related kidney donor as the source of a nearly fatal primary Epstein-Barr virus infection following transplantation. Transplantation 58:852

    PubMed  Google Scholar 

  53. Veronese ML, Veronesi A, D'Andrea E, Mistro ARD, Indraccol S, Mazza MR, Mion M, Zamarchi R, Menin C, Panozzo M, Amadori A, Chieco-Bianchi L (1992) Lymphoproliferative disease in human peripheral blood mononuclear cell-injected scid mice. I. T lymphocyte requirement for B cell tumour generation. J Exp Med 176:1763

    PubMed  Google Scholar 

  54. Wallace CE, Rickinson AB, Rowe M, Epstein MA (1982) Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature 297:413

    PubMed  Google Scholar 

  55. Weiss LM, Movahed LA (1989) In situ demonstration of Epstein-Barr viral genomes in viral-associated B lymphoproliferation. Am J Pathol 134:651

    PubMed  Google Scholar 

  56. Yao QY, Ogan P, Rowe M, Wood M, Rickinson AB (1989) Epstein-Barr virus immortalised B-cells persist in the circulation of acyclovir-treated virus carriers. Int J Cancer 43:67

    PubMed  Google Scholar 

  57. Young L, Alfieri C, Hennesy K (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med. 321:1080

    PubMed  Google Scholar 

  58. Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM (1988) Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, The University of Edinburgh Medical School, Teviot Place, EH8 9AG, Edinburgh, UK

    Tanzina Haque & Dorothy H. Crawford

Authors
  1. Tanzina Haque
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dorothy H. Crawford
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haque, T., Crawford, D.H. Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders. Springer Semin Immunopathol 20, 375–387 (1998). https://doi.org/10.1007/BF00838050

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00838050

Keywords

Search

Navigation